What is it about?

Delee founders aimed to change the way cancer radically is detected, monitored, and treated. They created a highly sensitive automated benchtop device for the rapid isolation and analysis of circulating tumor cells from blood samples to make this possible. Nevertheless, some questions arise when selecting a suitable business strategy to accomplish Delee’s vision.

Featured Image

Read the Original

This page is a summary of: Delee, transforming cancer detection and treatment, Emerald Emerging Markets Case Studies, October 2021, Emerald,
DOI: 10.1108/eemcs-12-2020-0430.
You can read the full text:

Read

Contributors

The following have contributed to this page